BBritain Read More Personalis NeXT Personal Dx Cancer Test Gains UKCA Mark for Great BritainAugust 7, 2026 Personalis Inc has achieved United Kingdom Conformity Assessed (UKCA) marking for its NeXT Personal Dx test. The regulatory…
AAstraZeneca Read More SOPHiA GENETICS, AstraZeneca Partner on Decentralized Oncology DiagnosticsAugust 5, 2026 SOPHiA GENETICS and AstraZeneca have entered a multi-year collaboration to develop, validate, and deploy two companion diagnostic programs…